Skip to main content
University of Wisconsin–Madison
UW Crest
Ophthalmology and Visual Sciences
  • Home
  • About Us Expand Collapse
    • About Us
    • Alumni
    • Careers
    • Directory
    • Giving
    • Leadership
  • Education Expand Collapse
    • Clinical Fellowships
    • Global Ophthalmology
    • Ophthalmology Clerkship
    • Orthoptist Training Program
    • Pre-Residency Fellowships
    • Residency Program
    • Vision Research Opportunities
    • Vision Research Training Program
    • Visiting Medical Students
  • Research Expand Collapse
    • A-EYE Research Unit
    • Clinical Eye Research Unit
    • Laboratories
    • Publications
    • Research Resources
    • Vision Research Core
    • Vision Research Training Program
    • WAIVS
    • Wisconsin Reading Center
  • Global Ophthalmology
  • People First
  • Events
  • Giving
  • News

Year: 2023

Selectively compromised inner retina function following hypoxic-ischemic encephalopathy in mice: A noninvasive measure of severity of the injury.

Posted on February 1, 2023

PubMed ID: 36592700 Author(s): Taparli OE, Shahi PK, Cagatay NS, Aycan N, Ozaydin B, Yapici S, Liu X, Cikla U, Zafer D, Eickhoff JC, Ferrazzano P, Pattnaik BR, Cengiz P. Selectively compromised inner retina function …

Posted in Bikash Pattnaik, Publications

Associations Between HbA1c Across the Normal Range, Diagnosed, and Undiagnosed Diabetes and Retinal Layer Thickness in UK Biobank Cohort.

Posted on February 1, 2023

PubMed ID: 36795065 Author(s): Chua SYL, Welsh P, Sun Z, Balaskas K, Warwick A, Steel D, Sivaprasad S, Channa R, Ko T, Sattar N, Khawaja AP, Foster PJ, Patel PJ; UK Biobank Eye and Vision …

Posted in Publications, Roomasa Channa

Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma.

Posted on February 1, 2023

PubMed ID: 36727336 Author(s): Kumari N, Jain N, Saboo S, Parthasarathy R, Gupta V, Mahajan A, Das S. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma. Indian J Ophthalmol. 2023 Feb;71(2):436-443. doi: 10.4103/ijo.IJO_1388_22. PMID 36727336 …

Posted in Publications, Sima Das

Commentary: Can machine be taught to detect retinoblastoma?

Posted on February 1, 2023

PubMed ID: 36727334 Author(s): Das S, Varshney A. Commentary: Can machine be taught to detect retinoblastoma? Indian J Ophthalmol. 2023 Feb;71(2):432-433. doi: 10.4103/ijo.IJO_2283_22. No abstract available. PMID 36727334 Journal: Indian Journal Of Ophthalmology, Volume 71, …

Posted in Publications, Sima Das

UW’s Low Vision Rehabilitation Offers Comprehensive Services to Patients

Posted on January 31, 2023

The National Eye Institute recognizes February as Low Vision Awareness Month. This places a spotlight on vision-related disabilities and the supportive infrastructure needed.

Posted in Featured News, Sanbrita MondalTagged Low Vision, Low Vision Rehabilitation

Cytochrome P450 1B1 Expression Regulates Intracellular Iron Levels and Oxidative Stress in the Retinal Endothelium.

Posted on January 26, 2023

PubMed ID: 36768740 Author(s): Song YS, Zaitoun IS, Wang S, Darjatmoko SR, Sorenson CM, Sheibani N. Cytochrome P450 1B1 Expression Regulates Intracellular Iron Levels and Oxidative Stress in the Retinal Endothelium. Int J Mol Sci. …

Posted in Ismail Zaitoun, Publications, Sheibani Lab

SANDCAT

Posted on January 23, 2023

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients with Uveitic Macular Edema (Sandcat)

Posted in Actively Recruiting, Clinical Trials, Laura Kopplin, Uveitic Macular Edema, UveitisTagged CERU, clinical trials, research, Uveitis

CapriCORN

Posted on January 23, 2023

Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the Cornea

Posted in Actively Recruiting, Clinical Trials, Cornea, Corneal Ulcer, Sarah NehlsTagged CERU, clinical trials, cornea, research

RECORDATI MT8

Posted on January 23, 2023

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops (MT8) for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Posted in Clinical Trials, Cornea, Evan Warner, Neurotrophic KeratitisTagged CERU, clinical trials, cornea, research
  • Previous page
  • 1
  • 15
  • 16
  • You're on page 17
  • 18
  • 19
  • 20
  • Next page

Site footer content



University logo that links to main university website


Quick Links

  • News
  • Contact Us
  • Giving
  • Intranet Login
  • UW-Madison School of Medicine and Public Health

Contact Us

  • 2828 Marshall Court
    Madison, WI 53705
    • facebook
    • instagram
    • linkedin

Website feedback, questions or accessibility issues: webmaster@ophth.wisc.edu.

This site was built using the UW Theme | Privacy Notice | © 2025 Board of Regents of the University of Wisconsin System.